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Corrigendum to: Hospital Readmissions After Laboratory-
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In “Hospital Readmissions After Laboratory-Confirmed 
Influenza Hospitalization” by Dobrzynski et  al [J Infec Dis 
2020; jiaa117], Figure 2B had incorrect values for the propor-
tion readmitted from Time from Index Hospitalization. These 
values have been re-labeled and the solid black line was graphed 
accordingly in the published version. Additionally, Figure 2B 
was incorrectly referenced after “Patients aged 65 years and older 
accounted for 1380 total readmissions, 215 of which occurred 
within 30 days among 188 patients (6%) (Figure 2B).”, which was 
removed in the published version. The authors regret these errors.
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In “A Randomized Clinical Trial to Compare Plasmodium fal-
ciparum Gametocytemia and Infectivity After Blood-Stage 
or Mosquito Bite–Induced Controlled Malaria Infection” by 
Alkema et  al [J Infect Dis 2020; jiaa157], data points for MB 
Inoculations and IBSM were erroneously reversed for the var-
iable: Individuals infectious to mosquitoes, % (no./total) in 
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